Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) was a big mover last session, as its shares rose almost 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Yesterday’s rally continues the uptrend for the company since May 12, as the stock is now up nearly 8%.
Over the last 30 days, the company witnessed one positive and seven negative estimate revisions. Meanwhile, the Zacks Consensus Estimate moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher lasts.
Alnylam Pharmaceuticals currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
A better-ranked biomedical stock is ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) with a Zacks Rank #1 (Strong Buy).
Is ALNY going up? Or down? Predict to see what others think: Up or Down
ALNYLAM PHARMA (ALNY): Free Stock Analysis Report
ANI PHARMACEUT (ANIP): Free Stock Analysis Report
Original post
Zacks Investment Research